BTG-1640 | CAS#152538-59-5

MedKoo Cat#: 530311 | Name: BTG-1640

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BTG-1640, also known as ABIO-0801; SP-1640; ABIO-08-01, a drug potentially for the treatment of anxiety and panic disorder.

Chemical Structure

BTG-1640

CAS#152538-59-5

Theoretical Analysis

MedKoo Cat#: 530311

Name: BTG-1640

CAS#: 152538-59-5

Chemical Formula: C15H19NO2

Exact Mass: 245.1416

Molecular Weight: 245.32

Elemental Analysis: C, 73.44; H, 7.81; N, 5.71; O, 13.04

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

BTG-1640; BTG 1640; BTG1640; ABIO-0801; SP-1640; ABIO-08-01.

IUPAC/Chemical Name

(3S,3aR,7aR)-3-benzyl-2-methylhexahydrobenzo[d]isoxazol-4(2H)-one

InChi Key

ALQXIMVNPRVWQA-CFVMTHIKSA-N

InChi Code

InChI=1S/C15H19NO2/c1-16-12(10-11-6-3-2-4-7-11)15-13(17)8-5-9-14(15)18-16/h2-4,6-7,12,14-15H,5,8-10H2,1H3/t12-,14+,15-/m0/s1

SMILES Code

O=C1[C@]2([H])[C@H](CC3=CC=CC=C3)N(C)O[C@]2([H])CCC1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 245.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Saletu B, Anderer P, Wolzt M, Nosiska D, Assandri A, Noseda E, Nannipieri F, Saletu-Zyhlarz GM. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography). Neuropsychobiology. 2009;59(2):110-22. doi: 10.1159/000212380. PubMed PMID: 19365151. 2: Saletu-Zyhlarz GM, Anderer P, Wolzt M, Semlitsch HV, Assandri A, Nessi P, Nannipieri F, Rosini S, Saletu B. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings. Neuropsychobiology. 2009;59(2):100-9. doi: 10.1159/000212379. PubMed PMID: 19365150. 3: Anderer P, Saletu B, Wolzt M, Culic S, Assandri A, Nannipieri F, Rosini S, Saletu-Zyhlarz GM. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography. Hum Psychopharmacol. 2008 Apr;23(3):243-54. doi: 10.1002/hup.920. PubMed PMID: 18181252.